ResMed Aktie
215,50
EUR
-1,30
EUR
-0,60
%
252,56
USD
+1,71
USD
+0,68
%
Werbung
ResMed Aktie Analyse
| 25.09.17 | ResMed Underweight | Barclays Capital | |
| 07.04.16 | ResMed Underweight | Barclays Capital | |
| 27.01.15 | ResMed Under Perform | Northland Capital |
Werbung
Werbung